Skip to content

Kenvue Inc. Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 30, 2026 results vs estimates

Kenvue Inc. · E.KVUE.NYSE · United States
Use symbol E.KVUE.NYSE in our API & Excel add-in to retrieve this data ↓
19.56
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 75%
Bubble Risk LOW
Realised Volatility (20D) 24.01%

Kenvue Inc. Forecast

Kenvue Inc. short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 24.0% a year, a typical one-standard-deviation range is 18.90–20.22 over a week, 18.20–20.92 over a month and 14.86–24.26 over a year. (Signals as of 1 Nov 2026.)

Kenvue Inc. Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Kenvue Inc.
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Kenvue Inc.
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Kenvue Inc.
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Kenvue Inc.
P/E
22.29x
Mid-range vs own history
QoQ +0.8%
YoY −0.2%
now 22.291519.95 low25.09 high
ⓘP/E As of 22 Nov 2026.See Kenvue Inc. returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Kenvue Inc.
P/S
2.43x
Mid-range vs own history
QoQ +2.0%
YoY +13.8%
now 2.42582.15 low2.49 high
ⓘP/S As of 22 Nov 2026.See Kenvue Inc. returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Kenvue Inc.
P/B
3.71x
Mid-range vs own history
QoQ +6.7%
YoY +23.2%
now 3.70723.04 low3.71 high
ⓘP/B As of 22 Nov 2026.See Kenvue Inc. returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Kenvue Inc.
EV/EBITDA
13.79x
Mid-range vs own history
QoQ −0.8%
YoY +1.5%
now 13.787412.77 low14.93 high
ⓘEV/EBITDA As of 22 Nov 2026.See Kenvue Inc. returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Kenvue Inc.
EV/Sales
2.90x
Mid-range vs own history
QoQ +1.4%
YoY +8.7%
now 2.8962.62 low2.99 high
ⓘEV/Sales As of 22 Nov 2026.See Kenvue Inc. returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Kenvue Inc.
FCF Yield
6.0%
Mid-range vs own history
QoQ +19.7%
YoY +17.3%
now 6.00764.56 low6.09 high
ⓘFCF Yield As of 22 Nov 2026.See Kenvue Inc. returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Kenvue Inc.
Earnings Yield
4.5%
Mid-range vs own history
QoQ −0.8%
YoY +0.2%
now 4.4863.98 low5.01 high
ⓘEarnings Yield As of 22 Nov 2026.See Kenvue Inc. returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Kenvue Inc.
Dividend Yield
6.3%
Mid-range vs own history
QoQ −2.5%
YoY +28.4%
now 6.32294.38 low7.21 high
ⓘDividend Yield As of 22 Nov 2026.See Kenvue Inc. returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Kenvue Inc.
Market Cap
$37.7B
Mid-range vs own history
QoQ +2.8%
YoY +17.7%
now 37672.5632,364 low38,113 high
ⓘMarket Cap As of 22 Nov 2026.See Kenvue Inc. returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Kenvue Inc.
Net Debt
$7.3B
Mid-range vs own history
QoQ −0.9%
YoY −8.4%
now 73027,302 low7,970 high
ⓘNet Debt As of 22 Nov 2026.See Kenvue Inc. returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Kenvue Inc.
Net Debt / EBITDA
2.24x
Mid-range vs own history
QoQ −3.8%
YoY −17.4%
now 2.23852.24 low2.71 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Kenvue Inc. returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Kenvue Inc.
Current Ratio
0.96x
Weak vs own history
QoQ −5.0%
YoY −2.5%
now 0.95540.96 low1.01 high
ⓘCurrent Ratio As of 22 Nov 2026.See Kenvue Inc. returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Kenvue Inc.
Quick Ratio
0.66x
Weak vs own history
QoQ −6.8%
YoY −3.6%
now 0.66340.66 low0.71 high
ⓘQuick Ratio As of 22 Nov 2026.See Kenvue Inc. returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Kenvue Inc.
Interest Coverage
6.96x
Strong vs own history
QoQ +0.7%
YoY +33.4%
now 6.95875.22 low6.96 high
ⓘInterest Coverage As of 22 Nov 2026.See Kenvue Inc. returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Kenvue Inc.
Debt / Equity
0.82x
Mid-range vs own history
QoQ +2.1%
YoY −4.2%
now 0.82080.79 low0.86 high
ⓘDebt / Equity As of 22 Nov 2026.See Kenvue Inc. returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Kenvue Inc.
Piotroski F-Score
7
Mid-range vs own history
QoQ −22.2%
YoY +16.7%
now 76 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Kenvue Inc. returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Kenvue Inc.
Altman Z-Score
2.25
Mid-range vs own history
QoQ −0.2%
YoY +13.5%
now 2.24871.99 low2.29 high
ⓘAltman Z-Score As of 22 Nov 2026.See Kenvue Inc. returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Kenvue Inc., red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Kenvue Inc. fundamentals: income statement, balance sheet & cash flow

Kenvue Inc. reported revenue of $15.12bn and net income of $1.47bn in FY2025, the year ended 31 December 2025 — revenue down 2.1% and net income up 42.7% on the prior year. Free cash flow was $1.72bn. These figures are as reported in the filings, not restated: 7 fiscal years and 20 quarters of history, back to December 2019. 82 FINRA short-interest settlements are published alongside them, back to May 2023.

Revenue (FY2025)
$15.12bn
-2.1%
Net income
$1.47bn
+42.7%
Gross margin
58.13%
Free cash flow
$1.72bn
+29.0%
Net debt
$7.46bn
Shares short (30 Oct 2026)
52.38m
2.52 days to cover
Kenvue Inc. income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue15.1215.4615.4414.9515.05
Cost of revenue6.336.506.806.676.64
Gross profit8.798.968.648.298.42
Research & development0.38—0.400.380.36
Selling, general & admin.—4.39———
Operating income2.701.842.512.682.92
EBITDA2.942.473.183.283.66
Interest expense0.380.430.360.000.00
Pre-tax income2.001.422.192.642.93
Income tax0.530.390.530.570.85
Net income1.471.031.662.062.08

Download Kenvue Inc. fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.KVUE.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks the full history, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Kenvue Inc.

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Kenvue Inc. Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLP (Consumer Staples sector), the closest tradable exposure to Kenvue Inc.; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLP →

Statistical Distribution of Returns

Plus

How Kenvue Inc.’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Kenvue Inc. behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Kenvue Inc. (United States)

Kenvue Inc. is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Kenvue Inc.?
Kenvue Inc. is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Kenvue Inc. price?
The latest close is 19.56 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Kenvue Inc. in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (7 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Kenvue Inc.?
20-day realised volatility is 24.0% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 6.9% over a month and 3.4% over a week.
What factors affect Kenvue Inc.?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Kenvue Inc., grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Kenvue Inc.?
58 backtested tactical asset allocation strategies trade Kenvue Inc. through SPY, XLP; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Kenvue Inc. returns analysed?
The Statistical Distribution of Returns section shows the distribution of Kenvue Inc. daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Kenvue Inc. historical data?
In the Free historical data section of this page: the last 10 years of Kenvue Inc. daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Kenvue Inc. historical data (last 10 years)

Browse or instantly download the last 10 years of Kenvue Inc. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.KVUE.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-10-3019.31
2026-10-2919.56
2026-10-2819.33
2026-10-2719.43
2026-10-2619.5
2026-10-2319.57
2026-10-2219.88
2026-10-2119.04
2026-10-2019.28
2026-10-1918.87
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.